WCA
PRAH

Westover Capital Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Westover Capital Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,993
Closed -$220K – 152
2019
Q1 		$220K Buy
+1,993
New +$208K 0.11% 125
2018
Q2 		– Sell
-7,385
Closed -$613K – 114
2018
Q1 		$613K Buy
+7,385
New +$656K 0.33% 71

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Westover Capital Advisors's PRAH Position: Q2 2019 in Review

Westover Capital Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2019, closing a stake of 1,993 shares — an estimated $220K sold.

Westover Capital Advisors first reported a position in PRAH in Q1 2018 and held it in 2 quarters. The position peaked at $613K in Q1 2018. 329 funds tracked by Wall St. Rank hold PRAH as of Q2 2019.

  • Westover Capital Advisors reported no remaining PRA Health Sciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • Westover Capital Advisors sold 1,993 PRA Health Sciences, Inc. shares in Q2 2019, an estimated $220K.
  • Westover Capital Advisors first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 2 quarters.
  • Westover Capital Advisors's PRA Health Sciences, Inc. position peaked at $613K in Q1 2018.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2019.

Based on Westover Capital Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.